These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35917060)

  • 1. Identification of post-procedural optical coherence tomography findings associated with the 1-year vascular response evaluated by coronary angioscopy.
    Higashino N; Ishihara T; Iida O; Tsujimura T; Hata Y; Toyoshima T; Nakao S; Kurata N; Mano T
    Cardiovasc Interv Ther; 2023 Jan; 38(1):86-95. PubMed ID: 35917060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular healing in high-bleeding-risk patients at 3-month after everolimus-eluting stent versus biolimus A9-coated stent implantation: insights from analysis of optical coherence tomography and coronary angioscopy.
    Koiwaya H; Nishihira K; Kadooka K; Kuriyama N; Shibata Y
    Cardiovasc Interv Ther; 2023 Jan; 38(1):64-74. PubMed ID: 35918588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early- and middle-phase arterial repair following bioresorbable- and durable-polymer drug-eluting stent implantation: An angioscopic study.
    Ishihara T; Tsujimura T; Okuno S; Iida O; Asai M; Masuda M; Okamoto S; Nanto K; Kanda T; Matsuda Y; Mano T
    Int J Cardiol; 2019 Jun; 285():27-31. PubMed ID: 30857848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Subclinical Intrastent Thrombus Detected 9 Months After Implantation of 2nd-Generation Drug-Eluting Stent With Future Major Adverse Cardiac Events　- A Coronary Angioscopic Study.
    Okuno S; Ishihara T; Iida O; Asai M; Masuda M; Okamoto S; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Takahara M; Uematsu M; Mano T
    Circ J; 2018 Aug; 82(9):2299-2304. PubMed ID: 29973431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.
    Kimura S; Sugiyama T; Hishikari K; Nakamura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1483-94. PubMed ID: 27423209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of neointimal coverage between durable-polymer everolimus-eluting stents and bioresorbable-polymer everolimus-eluting stents 1 year after implantation using high-resolution coronary angioscopy.
    Nojima Y; Adachi H; Ihara M; Kurimoto T; Okayama K; Sakata Y; Nanto S
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):204-209. PubMed ID: 30737973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
    Higo T; Ueda Y; Oyabu J; Okada K; Nishio M; Hirata A; Kashiwase K; Ogasawara N; Hirotani S; Kodama K
    JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Evaluation of Tissue Protrusion by Using Optical Coherence Tomography and Coronary Angioscopy Immediately After Stent Implantation.
    Sakai S; Sato A; Hoshi T; Hiraya D; Watabe H; Ieda M
    Circ J; 2020 Nov; 84(12):2235-2243. PubMed ID: 33055456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satisfactory arterial repair 1 year after ultrathin strut biodegradable polymer sirolimus-eluting stent implantation: an angioscopic observation.
    Ishihara T; Awata M; Iida O; Fujita M; Masuda M; Okamoto S; Nanto K; Kanda T; Tsujimura T; Uematsu M; Mano T
    Cardiovasc Interv Ther; 2019 Jan; 34(1):34-39. PubMed ID: 29335827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Morphological Predictors of Intrastent Coronary Thrombus After Drug-Eluting Stent Implantation (from a Multicenter Registry).
    Gao L; Lee S; Kim CJ; Minami Y; Ong DS; Soeda T; Lowe H; Choi SY; Lerman A; Lee J; Lee H; Uemura S; Yu B; Jang IK
    Am J Cardiol; 2016 Feb; 117(3):369-75. PubMed ID: 26705880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC; Michael TT; Yangirova D; Abdel-Karim AR; Kohlhaas J; Mahmood A; Addo T; Haagen D; Makke L; Roesle M; Rangan B; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2012 Aug; 24(8):390-4. PubMed ID: 22865309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Neointimal Condition and Platelet Reactivity on Intrastent Thrombus at Long-Term Follow-up After 2nd- and 3rd-Generation Drug-Eluting Stent Implantation　- Insights From a Coronary Angioscopy and Pharmacodynamic Study.
    Matsuura T; Ueno M; Watanabe H; Yasuda M; Takase T; Nakamura T; Yamaji K; Iwanaga Y; Miyazaki S; Nakazawa G
    Circ J; 2020 Nov; 84(12):2244-2252. PubMed ID: 33162462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study.
    Giglioli C; Formentini C; Romano SM; Cecchi E; Baldereschi GJ; Landi D; Chiostri M; Prati F; Marchionni N
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):217-230. PubMed ID: 31667661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents.
    Tomaniak M; Kołtowski Ł; Pietrasik A; Rdzanek A; Jąkała J; Proniewska K; Malinowski K; Mazurek T; Filipiak KJ; Brugaletta S; Opolski G; Kochman J
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):9-21. PubMed ID: 30168010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation.
    Ishihara T; Sotomi Y; Tsujimura T; Iida O; Kobayashi T; Hamanaka Y; Omatsu T; Sakata Y; Higuchi Y; Mano T
    Cardiovasc Diabetol; 2020 Dec; 19(1):203. PubMed ID: 33267863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.